p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making
Polish Journal of Pathology · 25.06.2026 · 77 (2) · 195-202
DOI: 10.5114/pjp.2026.162576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polish Journal of Pathology, online erschienen am 25.06.2026. Verfasst von Martyna Trzeszcz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology and Clinical Cytology, University Hospital in Wroclaw, Wroclaw, Poland. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Immunohistochemistry, Cyclin-Dependent Kinase Inhibitor p16, Papillomavirus Infections. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Cervical cancer prevention has undergone a major shift with the implementation of human papillomavirus (HPV)-based screening, which offers high sensitivity but limited specificity due to the detection of transient infections. This has created a need for triage methods capable of identifying infections associated with clinically meaningful disease. Primary HPV testing provides a high level of reassurance when negative; however, individuals with a positive result require additional evaluation using triage methods that effectively identify precancerous lesions while avoiding unnecessary colposcopy referrals. This review addresses the role of p16/Ki-67 dual-stain (DS) immunocytochemistry as a biomarker of transforming HPV infection, with a focus on HPV-based screening settings. We discuss its biological basis and diagnostic performance in comparison with cytology, with particular attention to the principles and practical aspects of DS interpretation in routine cytopathological practice. We also summarize current evidence, including data from national studies and routine clinical practice, demonstrating that DS can be effectively integrated into screening pathways and support more informed clinical decision-making. Its increasing use reflects the broader transition toward biologically informed cervical cancer prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pathology and Clinical Cytology, University Hospital in Wroclaw, Wroclaw, Poland.
- Corfamed Woman's Health Center, Wroclaw, Poland.
- Division of Gynecologic Endocrinology, Jagiellonian University Medical College, Cracow, Poland.
Zitieren
APA
Trzeszcz, M., & Jach, R. (2026). p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making. Polish Journal of Pathology, 77(2), 195-202. https://doi.org/10.5114/pjp.2026.162576
Vancouver
Trzeszcz M, Jach R. p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making. Polish Journal of Pathology. 2026;77(2):195-202. doi:10.5114/pjp.2026.162576
BibTeX
@article{Trzeszcz2026,
author = {Trzeszcz, Martyna and Jach, Robert},
title = {p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making},
journal = {Polish Journal of Pathology},
year = {2026},
volume = {77},
number = {2},
pages = {195--202},
doi = {10.5114/pjp.2026.162576}
}
EUVIMED